March 25, 2026 09:21 pm (IST)
Zydus Cadila receives USFDA approval to market Carboplatin Injection
Ahmedabad, Apr 1 (IBNS) Zydus Cadila, a fully integrated, global healthcare provider, announced on Friday that it has received the final approval from the USFDA to market Carboplatin Injection, 10 mg/ml in 5 ml, 15 ml and 45 ml.
The group now has more than 100 approvals and has so far filed over 280 ANDAs since the commencement of the filing process in FY 2003-04.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
Latest Headlines
Dada’s next innings for a sustainable future: Sourav Ganguly joins hands with Jakson Group
Wed, Mar 25 2026
L&T gains 3% after securing Assam water management project
Wed, Mar 25 2026
Sensex surges 1,200 pts, Nifty tops 23,300 as markets rally; experts warn of volatility
Wed, Mar 25 2026
Epic Games axes 1,000 employees — Is Fortnite losing its magic?
Wed, Mar 25 2026
What to Do When Home Loan Interest Rates Go Up
Tue, Mar 24 2026
